New study aims to uncover hidden swelling after urologic cancer surgery
NCT ID NCT05264337
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 400 patients who have had urologic cancer surgery with lymph node removal to see how often they develop lymphedema (leg swelling). Researchers will use questionnaires and special devices to measure swelling and tissue fluid over two years. The goal is to better understand this common but understudied side effect.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict and manage lymphedema after urologic cancer surgery.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures outcomes and does not test any new therapy, so it cannot directly improve patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PENILE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sahlgrenska University Hospital
RECRUITINGGothenburg, 41345, Sweden
-
Örebro University Hospital
RECRUITINGÖrebro, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug deliver a toxic payload to prostate cancer cells?
- Can AI outthink cancer experts? a landmark trial pits five AIs against tumor boards
- Bladder cancer surgery: what happens after the bladder is removed?
- Hormone therapy showdown: can an oral pill beat the shot for prostate cancer patients?
- Can a new daily pill slow advanced prostate cancer?
- Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.